Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"WHO International Clinical Trials Registry Platform"
publishDate:"[2021 TO 2021]"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=publishDate%3A%22%5B2021+TO+2021%5D%22&lookfor=Dexamethasone+OR+corticosteroid&type=AllFields&page=6
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=publishDate%3A%22%5B2021+TO+2021%5D%22&lookfor=Dexamethasone+OR+corticosteroid&type=AllFields&page=6
Search /vufind/Search2/Results?filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=publishDate%3A%22%5B2021+TO+2021%5D%22&lookfor=Dexamethasone+OR+corticosteroid&type=AllFields&page=6
PubPharm (1.746)
51
A randomised, double-blind, active-controlled study to evaluate the impact of stepwise withdrawal of inhaled corticosteroid treatment in patients with severe to very severe chronic obstructive pulmonary disease (COPD) on optimised bronchodilator therapy. : A randomised, double-blind, active-controlled study to evaluate the impact of stepwise withdrawal of inhaled corticosteroid treatment in patients with severe to very severe chronic obstructive pulmonary disease (COPD) on optimised bronchodilator therapy.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
52
A Phase 2, Randomized Study of VELCADE® (bortezomib), Dexamethasone, and Thalidomide Versus VELCADE® (bortezomib), Dexamethasone, Thalidomide, and Cyclophosphamide in Subjects With Previously Untreated Multiple Myeloma Who are Candidates for Autologous Transplantation. : A Phase 2, Randomized Study of VELCADE® (bortezomib), Dexamethasone, and Thalidomide Versus VELCADE® (bortezomib), Dexamethasone, Thalidomide, and Cyclophosphamide in Subjects With Previously Untreated Multiple Myeloma Who are Candidates for Autologous Transplantation.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
53
A Study to Evaluate Daratumumab in Transplant Eligible Participants with Previously Untreated Multiple Myeloma : Study of Daratumumab in Combination with Bortezomib (VELCADE), Thalidomide, and Dexamethasone (VTD) in the First Line Treatment of Transplant Eligible Subjects with Newly Diagnosed Multiple Myeloma - CASSIOPEIA
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
54
A study evaluating safety and efficacy of Itacitinib or Placebo in combination with corticosteroids as initial treatment of chronic graft versus-host disease : GRAVITAS-309: A Phase 2/3 Study of Itacitinib and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease - GRAVITAS-309
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
55
Bortezomib, Selinexor and Dexamethasone in Patients with Multiple Myeloma : A Phase 3 Randomized, Controlled, Open-label Study of Selinexor, Bortezomib, and Dexamethasone (SVd) versus Bortezomib and Dexamethasone (Vd) in Patients with Relapsed or Refractory Multiple Myeloma (RRMM) - BOSTON
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
56
Efficacy and safety of lebrikizumab in patients withAD not adequately controlled or non-eligible forcyclosporine : A Randomised, Double-Blind, Placebo-ControlledPhase 3 Clinical Trial to Assess the Efficacy andSafety of Lebrikizumab in Combination With TopicalCorticosteroids in Adult and Adolescent PatientsWith Moderate-To-Severe Atopic Dermatitis ThatAre Not Adequately Controlled With Cyclosporine orFor Whom Cyclosporine is Not Medically Advisable. - ADvantage
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
57
A Randomized Study Comparing Bortezomib, Lenalidomide and Dexamethasone (VRd) followed by Ciltacabtagene Autoleucel versus Bortezomib, Lenalidomide, and Dexamethasone (VRd) followed by Lenalidomide and Dexamethasone (Rd) Therapy in Participants with Newly Diagnosed Multiple Myeloma for Whom Stem Cell Transplant is Not Planned as Initial Therapy : A Phase 3 Randomized Study Comparing Bortezomib, Lenalidomide and Dexamethasone (VRd) followed by Ciltacabtagene Autoleucel, a Chimeric Antigen Receptor T cell (CAR-T) Therapy Directed Against BCMA versus Bortezomib, Lenalidomide, and Dexamethasone (VRd) followed by Lenalidomide and Dexamethasone (Rd) Therapy in Participants with Newly Diagnosed Multiple Myeloma for Whom Hematopoietic Stem Cell Transplant is Not Planned as Initial Therapy - CARTITUDE-5
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
58
Study on Bioequivalence of Desonide Cream in Human Body : Study on Bioequivalence of Desonide Cream in Human Body
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
59
INVESTIGATING NEW ONSET DIABETES MELLITUS IN KIDNEY TRANSPLANT RECIPIENTS RECEIVING AN ADVAGRAF-BASED IMMUNOSUPPRESSIVE REGIMEN WITH OR WITHOUT CORTICOSTEROIDS – A MULTICENTER, TWO ARM, RANDOMIZED, OPEN LABEL CLINICAL STUDY - ADVANCE : INVESTIGATING NEW ONSET DIABETES MELLITUS IN KIDNEY TRANSPLANT RECIPIENTS RECEIVING AN ADVAGRAF-BASED IMMUNOSUPPRESSIVE REGIMEN WITH OR WITHOUT CORTICOSTEROIDS – A MULTICENTER, TWO ARM, RANDOMIZED, OPEN LABEL CLINICAL STUDY - ADVANCE
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
60
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of MTPS9579A in Patients with Asthma Requiring Inhaled Corticosteroids and a Second Controller : A PHASE IIa, MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY TO EVALUATE THE EFFICACY, SAFETY, AND PHARMACOKINETICS OF MTPS9579A IN PATIENTS WITH ASTHMA REQUIRING INHALED CORTICOSTEROIDS AND A SECOND CONTROLLER
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
[1]
« Vorheriger
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[175]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Zeitschrift: WHO International Clinical Trials Registry Platform
Filter aufheben
Erscheinungsjahr: 2021-2021
Medienart
1.746
Aufsätze
1.746
E-Artikel
1.746
E-Ressourcen
Zeitschriftentitel
WHO International Clinical Trials Registry Plat...
Thema
1.724
610
1.664
Study Type: Interventional
778
Recruitment Status: Not yet recruiting
506
Phase: Phase 3
344
Recruitment Status: Authorised-recruitment may ...
284
Recruitment Status: Completed
272
Phase: Phase 2
242
Recruitment Status: Recruiting
138
Phase: Phase 4
74
Phase: Phase 1
70
Medical Condition: Health Condition 1: O- Medic...
50
Study Type: Observational
48
Medical Condition: Multiple Myeloma MedDRA vers...
42
Phase: Phase 2/Phase 3
28
Medical Condition: Multiple myeloma MedDRA vers...
28
Phase: Post Marketing Surveillance
24
Medical Condition: Moderate and Severe Atopic D...
22
Medical Condition: Relapsed or Refractory Multi...
22
Medical Condition: corticosteroid-refractory ac...
20
Phase: Phase 3/Phase 4
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2021-2021
Erscheinungsjahr(e)
Von:
Bis:
Sprache
1.688
Englisch
54
Unbestimmt
4
Spanisch
Haven't found what you're looking for?
Wird geladen...